Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
Completed · Phase 2
Conditions studied: Schizophrenia
In brief
This study is to determine the efficacy (how well the drug works), safety, and side effects of the study medication compared to placebo in the treatment of the negative symptoms of schizophrenia in adults.
Key facts
- Study ID
- NCT00063297
- Run by
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- People needed
- 180
- Starts
- 2003-05-01
- Expected to finish
- 2003-10-01
- Last updated by the study team
- 2009-08-28
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Birmingham Psychiatry Pharmaceutical Studies, Inc. — Birmingham, Alabama, United States
- IPR — Cerritos, California, United States
- Synergy Clinical Research — Chula Vista, California, United States
- Optimum Health Services — La Mesa, California, United States
- Sierra Vista Hospital — Sacramento, California, United States
- Clinical Innovations — Santa Ana, California, United States
- Research Strategies — Torrance, California, United States
- University of Colorado — Denver, Colorado, United States
- Psychiatric Institute of Washington — Washington D.C., District of Columbia, United States
- Berma Research Group — Hialeah, Florida, United States
- Segal Institute for Clinical Research — North Miami, Florida, United States
- Quantum Laboratories — Pompano Beach, Florida, United States
- Med Psych Specialists, LLC — Atlanta, Georgia, United States
- Alexian Brothers Behavioral Health Hospital — Hoffman Estates, Illinois, United States
- Midwest Center for Neurobehavioral Medicine — Oakbrook Terrace, Illinois, United States
- Study site — Shreveport, Louisiana, United States
- University of Mississippi Medical Center-Dept. of Psychiatry — Jackson, Mississippi, United States
- CNS Research Institute — Clementon, New Jersey, United States
- Neurobehavioral Research — Lawrence, New York, United States
- Global Research & Consulting — Olean, New York, United States
- Bayley Seton Campus-Psychiatric Research Division — Staten Island, New York, United States
- Behavioral Medical Research of Staten Island, P.C. — Staten Island, New York, United States
- NorthCoast Clinical Trials — Beachwood, Ohio, United States
- IPS Research — Oklahoma City, Oklahoma, United States
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.